PolyNovo Limited Price (PNV.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

700,382,751

(2.3272)%

PolyNovo Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $1.125-2.78
  • Market Cap 870.46M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Mr. Swami Raote BPHARM, M.B.A.
  • IPO Date: November, 30, 1998
  • Country: AU
  • Currency: AUD
  • Headquaters: Port Melbourne, VIC
  • Employees: 282

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation